Skip to main content
Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
12.04
+0.02 (0.17%)
Dec 20, 2024, 4:00 PM EST - Market closed

Neogen Revenue

Neogen had revenue of $216.96M in the quarter ending August 31, 2024, a decrease of -5.25%. This brings the company's revenue in the last twelve months to $912.20M, down -0.75% year-over-year. In the fiscal year ending May 31, 2024, Neogen had annual revenue of $924.22M with 12.37% growth.

Revenue (ttm)
$912.20M
Revenue Growth
-0.75%
P/S Ratio
2.86
Revenue / Employee
$312,718
Employees
2,917
Market Cap
2.61B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 2024924.22M101.78M12.37%
May 31, 2023822.45M295.29M56.01%
May 31, 2022527.16M58.70M12.53%
May 31, 2021468.46M50.29M12.03%
May 31, 2020418.17M3.98M0.96%
May 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro
May 31, 2017 Pro Pro Pro
May 31, 2016 Pro Pro Pro
May 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Surgery Partners 2.99B
Concentra Group Holdings Parent 1.88B
LivaNova 1.24B
HUTCHMED (China) 610.81M
Catalyst Pharmaceuticals 460.48M
Protagonist Therapeutics 323.80M
SpringWorks Therapeutics 135.49M
Kymera Therapeutics 87.56M
Revenue Rankings

NEOG News

More News